{"id":"W1564728191","doi":"10.1038/bjc.2015.196","title":"Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University Hospital Foundation","funders":"Astellas Pharma; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Royal Marsden NHS Foundation Trust; Pfizer; Bristol-Myers Squibb","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Neutropenia; Expanded access; Internal medicine; Adverse effect; Clear cell renal cell carcinoma; Tyrosine-kinase inhibitor; Oncology; Confidence interval; Surgery; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01031016,0.001222683,0.002302667,0.0003705853,0.0005386074,0.001371221,0.0006451873,0.001010881,0.002500712],"category_scores_gemma":[0.004900476,0.0002637036,0.002611295,0.0005217833,0.0004978879,0.0007370478,0.0008699434,0.001787903,0.0006957551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009000191,"about_ca_system_score_gemma":0.001213893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001116804,"about_ca_topic_score_gemma":0.002941004,"domain_scores_codex":[0.9969241,0.00185877,0.000176372,0.0002482483,0.000427,0.0003654983],"domain_scores_gemma":[0.9957439,0.001430595,0.0008143071,0.0004350277,0.0005155178,0.001060608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6144797,0.008333357,0.07367681,0.003941808,0.01406855,0.002110194,0.0006757783,0.01192287,0.02078546,0.0004786633,0.0554262,0.1941006],"study_design_scores_gemma":[0.2684162,0.2260899,0.4210535,0.0006024993,0.01497693,0.003509029,0.0002195742,0.003169447,0.01113566,0.001534152,0.04906681,0.0002264501],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9390024,0.02634825,0.00397051,0.002571679,0.0005066778,0.00269679,0.0151126,0.0003349286,0.009456182],"genre_scores_gemma":[0.948898,0.003085666,0.003689946,0.002797852,0.0003905324,0.002475024,0.03417622,0.0001575654,0.0043292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01031016,"threshold_uncertainty_score":0.05452597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1058398097867058,"score_gpt":0.3561710599735537,"score_spread":0.2503312501868479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}